# Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.

> **NCT06379685** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 32 (estimated)

## Conditions studied

- Dry Eye
- Dry Eyes Chronic
- Dry Eye Syndromes

## Interventions

- **DRUG:** PRO-190
- **DRUG:** Systane Ultra®

## Key facts

- **NCT ID:** NCT06379685
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06379685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06379685, "Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06379685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*